FLUMIST (AstraZeneca Pty Ltd)
Product name
FLUMIST
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
191 (255 working days)
Active ingredients
Influenza virus
Registration type
EOI
Indication
FLUMIST is indicated for the prevention of influenza in children and adolescents from 24 months to less than 18 years of age.